Profile
Michael Gammons is currently Chief Information Officer & Vice President at Aurinia Pharmaceuticals, Inc., a position held since 2021.
Formerly, Mr. Gammons was Director-Information Systems Business Management at AstraZeneca PLC from 2004 to 2015, Chief Information Officer at Sucampo Pharmaceuticals LLC from 2015 to 2018, and Chief Information Officer at Autolus Therapeutics Plc from 2018 to 2021.
Mr. Gammons completed an MBA at Hood College and an undergraduate degree at West Virginia University.
Michael Gammons active positions
| Companies | Position | Start |
|---|---|---|
| AURINIA PHARMACEUTICALS INC. | Chief Tech/Sci/R&D Officer | 01/05/2021 |
Former positions of Michael Gammons
| Companies | Position | End |
|---|---|---|
| AUTOLUS THERAPEUTICS PLC | Chief Tech/Sci/R&D Officer | 01/01/2021 |
| SUCAMPO PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 01/01/2018 |
| ASTRAZENECA PLC | Corporate Officer/Principal | 01/01/2015 |
Training of Michael Gammons
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
AstraZeneca PLC
AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Hood College
Hood College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
West Virginia University
West Virginia University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sucampo Pharmaceuticals LLC
Sucampo Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Manufactures prostone based pharmaceuticals products | Health Technology |
Aurinia Pharmaceuticals, Inc.
Aurinia Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company, which focuses on discovery and development of immunomodulating therapeutics | Health Technology |
Autolus Therapeutics Plc
Autolus Therapeutics Plc Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of gene therapies | Health Technology |
- Stock Market
- Insiders
- Michael Gammons
















